Norfield Capital LLC 13D/13G Filings for OncoCyte Corporation (OCX)

Norfield Capital LLC 13D and 13G filings for OncoCyte Corporation:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-11-23
5:52 pm
Purchase
2022-11-1113GOncoCyte Corporation
OCX
Norfield Capital LLC330,018
5.500%
330,018increase
(New Position)
Filing